MedTech Acquisition (MTAC) Stock Price, News & Analysis

Company Overview

MedTech Acquisition Corporation does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the healthcare sector in the United States. The company was incorporated in 2020 and is based in Greenwich, Connecticut. MedTech Acquisition Corporation operates as a subsidiary of Medtech Acquisition Sponsor LLC.

Key Stats

• Today's Range: $8.96 to $12.83
• 50-Day Range: $9.34 to $11.34
• 52-Week Range: $8.43 to $12.83
• Volume: 183,276 shs
• Average Volume: 9,656 shs
• Market Capitalization: $83.80 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

MTAC Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of MedTech Acquisition own?

Based on aggregate information from My MarketBeat watchlists, some other companies that MedTech Acquisition investors own include Ginkgo Bioworks (DNA), BYD (BYDDY), Spire Global (SPIR), Altimeter Growth (AGC), ARK Innovation ETF (ARKK), Berkshire Hathaway (BRK.B) and Coinbase Global (COIN).

Company Calendar

• Today: 12/22/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Medical laboratories
• Sub-Industry: N/A
• Current Symbol: NASDAQ:MTAC
• CUSIP: N/A
• CIK: 1826667
• Web: N/A
• Phone: 908-391-1288
• Fax: N/A
• Employees: 3
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $5.54 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -17.92%
• Return on Assets: -1.48%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.03
• Quick Ratio: 0.03

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: $0.89 per share
• Price / Cash Flow: 12.80
• Book Value: ($2.04) per share
• Price / Book: -5.56

Miscellaneous

• Outstanding Shares: 7,390,000
• Free Float: 1,952,000
• Market Cap: $83.80 million
• Optionable: Not Optionable
• Beta: -0.04